All type of patients: 14 trials - CAROLINA - Gallwitz - Gomis - Forst - Lewin - Del Prato - linagliptin 1218.46 - linagliptin 1218.61 - linagliptin 1218.62 - linagliptin 1218.65 - linagliptin1218.5 - linagliptine 1218.50 - Owens - Taskinen
All types of patients: 14 trials - CAROLINA - Gallwitz - Gomis - Forst - Lewin - Del Prato - linagliptin 1218.46 - linagliptin 1218.61 - linagliptin 1218.62 - linagliptin 1218.65 - linagliptin1218.5 - linagliptine 1218.50 - Owens - Taskinen
Drug naïve patients: 1 trials - Del Prato
Patients inadequately controlled on MET+SU therapy : 1 trials - Owens
Patients inadequately controlled on metformin: 3 trials - Gallwitz - linagliptin 1218.62 - linagliptin 1218.65
Patients inadequately controlled on monotherapy : 4 trials - Gallwitz - Lewin - linagliptin 1218.62 - linagliptin 1218.65
Patients inadequately controlled on TZD: 1 trials - linagliptin 1218.61
Patients insufficiently controlled on SU: 1 trials - Lewin
Patients with insufficient glycaemic control with bitherapy: 2 trials - linagliptin 1218.61 - Owens